Quan Hong
- Co-authors
- Loretta M. ItriTrishna GoswamiYohann LoriotArjun Vasant BalarDaniel P. PetrylakPhillip L. PalmbosPetros GrivasRohit Jain
- Topics
- Cancer Immunotherapy and Biomarkers (7 papers)Cancer Treatment and Pharmacology (6 papers)HER2/EGFR in Cancer Research (6 papers)
- Partner nations
- United StatesFranceChina
In The Last Decade
Quan Hong
25 papers receiving 929 citations
Hit Papers
Peers
Comparison fields: 5 of 57
- Oncology 676
- Pulmonary and Respiratory Medicine 257
- Surgery 256
- Molecular Biology 212
- Immunology 162
Countries citing papers authored by Quan Hong
This map shows the geographic impact of Quan Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quan Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quan Hong more than expected).
Fields of papers citing papers by Quan Hong
This network shows the impact of papers produced by Quan Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quan Hong. The network helps show where Quan Hong may publish in the future.
Co-authorship network of co-authors of Quan Hong
This figure shows the co-authorship network connecting the top 25 collaborators of Quan Hong. A scholar is included among the top collaborators of Quan Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Quan Hong. Quan Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 68 | |
| 4 | 11 | |
| 5 | 47 | |
| 6 | 5 | |
| 7 | 7 | |
| 8 | 12 | |
| 9 | TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitorsbreakdown → | 351 |
| 10 | 89 | |
| 11 | 5 | |
| 12 | 15 | |
| 13 | 11 | |
| 14 | 26 | |
| 15 | 12 | |
| 16 | Long-term follow-up on the effects of sigmoid-rectal pouch for urinary diversion. | 1 |
| 17 | 118 | |
| 18 | 10 | |
| 19 | 30 | |
| 20 | 1 |
About Quan Hong
Quan Hong is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 26 papers that have together received 941 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Cancer Treatment and Pharmacology (6 papers) and HER2/EGFR in Cancer Research (6 papers). The work is most often cited by research in Oncology (676 citations), Pulmonary and Respiratory Medicine (257 citations) and Immunology (162 citations). Quan Hong has collaborated with scholars based in United States, France and China. Frequent co-authors include Loretta M. Itri, Trishna Goswami, Yohann Loriot, Arjun Vasant Balar, Daniel P. Petrylak, Phillip L. Palmbos, Petros Grivas, Rohit Jain, Manojkumar Bupathi and Neeraj Agarwal. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Nephrology Dialysis Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.